Sean has deep expertise in medical device manufacturing, and he will play a key role in the production of Spartan’s DNA devices and tests. -Paul Lem, M.D., CEO of Spartan Bioscience
Ottawa, Ontario (PRWEB) December 15, 2015
Spartan Bioscience today announced that Sean Tomalty has been named Vice President, Manufacturing. Mr. Tomalty will lead the manufacturing of Spartan’s DNA diagnostic devices and tests.
“Sean is an excellent addition to Spartan’s leadership team,” said Paul Lem, M.D., CEO of Spartan Bioscience. “Sean has deep expertise in medical device manufacturing, and he will play a key role in the production of Spartan’s DNA devices and tests.”
Mr. Tomalty joins Spartan with more than 30 years of experience in operations and manufacturing at companies including Abbott Point of Care, JDSU, and Nortel. At Abbott, he was Plant Director of a 500,000 square-foot medical device manufacturing facility that produced the i-STAT® portable clinical analyser and 35 million test cartridges annually.
Mr. Tomalty holds a Bachelor of Mechanical Engineering degree from Carleton University and a Masters of Business Administration degree from Queen’s University. He is a licensed Professional Engineer.
For more information about careers at Spartan, please visit http://www.spartanbio.com/about-us/careers/.
About Spartan Bioscience
Spartan Bioscience is the leader in on-demand DNA testing.(1) Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan’s technology fully integrates DNA collection, extraction, and analysis, with an intuitive interface that is easy to operate. For the first time, healthcare providers and their patients can get DNA results on demand. For more information, please visit our website at: http://www.spartanbio.com.
The Spartan logo is a registered trademark of Spartan Bioscience Inc.
i-STAT is a registered trademark of Abbott Point of Care Inc.
1. Roberts JD et al. (2012). Lancet. 379:1705–11.